AKT1 and hepatocellular carcinoma: Through both in vitro and in vivo methods like gene knockdown or overexpression, it was found that LEF1-AS1 enhanced cisplatin resistance in HCC cells by targeting miR-10a-5p to elevate MSI1 expression and actuate the AKT signaling pathway (Gao et al., 2021).